Ok, let's say the SEC is looking at them, NGIO is trying to get listed. NGIO is technically NOT Generex. Generex is not getting listed, NGIO is. NGIO is supposed to be a 'very clean listing' according to Joe. He stated that to all of us. That was emphasized. So, any look from the SEC should technically have no bearing on Generex, but on NGIO. So, Generex should still be able to provide information on what is going on with the Generex side of the house.

Or am I missing something here?